Pancreatic Cancer Research

ResearcherGuangzhou First People's HospitalActive in the last 2 years

Fang Wei

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-4820-4718; OpenAlex author ID A5030992386. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 2 papers

Papers 3

  1. Cingulin is an RNA-binding protein promoting pancreatic cancer through enhancing importin 7-mediated phospho-ERK nuclear translocation. First author DOI 10.1016/j.celrep.2025.115925↗
  2. Machine learning-driven prognostic model based on sphingolipid-related gene signature in pancreatic cancer: development and validation. Last author DOI 10.21037/tcr-24-1893↗
  3. Nuclear GRP78 Promotes Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-23-1143↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Keping Xie · 3 shared papers, 2023–2025 · strength 0.67
  2. Qi Zou · 1 shared paper, 2025 · strength 0.28
  3. Yuling Su · 1 shared paper, 2025 · strength 0.22
  4. Ping Liang · 1 shared paper, 2025 · strength 0.22
  5. Xiangyu Kong · 1 shared paper, 2023 · strength 0.17
  6. Tiansuo Zhao · 1 shared paper, 2023 · strength 0.17
  7. Fanyang Kong · 1 shared paper, 2023 · strength 0.17
  8. Qihui Sun · 1 shared paper, 2023 · strength 0.17
  9. Shaofei Chang · 1 shared paper, 2023 · strength 0.17
  10. Jihui Hao · 1 shared paper, 2023 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.